Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins.
about
Translating transitions - how to decipher peripheral human B cell developmentVaccine approaches for multidrug resistant Gram negative infectionsImmunogenicity of peanut proteins containing poly(anhydride) nanoparticles.Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells.Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.Cell clustering and delay/arrest in T-cell division implicate a novel mechanism of immune modulation by E. coli heat-labile enterotoxin B-subunits.Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.Cellular Dynamics of Memory B Cell Populations: IgM+ and IgG+ Memory B Cells Persist Indefinitely as Quiescent Cells.Norepinephrine potentiates proinflammatory responses of human vaginal epithelial cells.Limited clonal relatedness between gut IgA plasma cells and memory B cells after oral immunization.Modulation of Phenotype and Function of Human CD4+CD25+ T Regulatory Lymphocytes Mediated by cAMP-Elevating AgentsMechanisms of Cholera Toxin in the Modulation of TH17 Responses.Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.Induction of gut IgA production through T cell-dependent and T cell-independent pathways.The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza.Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties.Recent progress concerning CpG DNA and its use as a vaccine adjuvant.Intranasal formulations: promising strategy to deliver vaccines.The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization.Current state and challenges in developing oral vaccines.The regulation of gut mucosal IgA B-cell responses: recent developments.Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus.Activated T follicular helper-like cells are released into blood after oral vaccination and correlate with vaccine specific mucosal B-cell memory.Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice.Targeting Mycobacterium tuberculosis Antigens to Dendritic Cells via the DC-Specific-ICAM3-Grabbing-Nonintegrin Receptor Induces Strong T-Helper 1 Immune Responses.Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain.
P2860
Q26799037-C4967692-62B1-4C19-8710-EEB42838309FQ27007042-F9C34DA2-1313-4865-87F9-F05A40ACFC63Q34057755-F1F57731-F433-447A-80B3-76DF7B53D9D8Q34739851-69C3C833-7AB8-49DB-B668-ED02507F3A20Q35082439-F3FDD79A-F768-434B-A776-ADFAE34EAA54Q35630112-A899C2C3-836F-4FC8-BB6A-BD15F82D7837Q36173746-ED202B3D-DDC3-4527-B0ED-51EC3B45D46FQ36260505-39884763-5C4E-4C24-8A8B-312C93DF61CFQ36844071-276F05E5-91A1-44FA-95C7-586CC66E9EE6Q37261111-06C0978A-8C47-45E7-B75A-7E0299AB3826Q37266957-1FD5B36A-3B95-46BD-8518-75983CCCC2F5Q37641941-87EE5F26-292B-40C2-88F5-B00512B31B2FQ37963475-C6D1AF74-7A33-4B89-A3D2-640CDDD298BAQ37977139-9B1ACF50-7E12-4FF3-B08F-73A504AE76A7Q38001862-615E217C-20AC-4C1E-A8E5-54F6C9875FB3Q38058640-F857FE4A-C5B6-44E5-84C7-A5CCA2166312Q38168903-BE54BD90-D541-41CC-8EBE-8F43B70453C2Q38223050-16BA522D-83B1-4B4A-8783-1E07715DACCEQ39168847-766AA3FA-2B94-4E26-8186-AEBCAD99A011Q39259629-2461B919-4FC2-44E8-A4FE-562B2F20A41CQ39459081-DDF8B14C-FE94-4CA2-B2AB-E298EA35A225Q46749615-8F6E1603-AC91-4A4C-A3D6-111219968C46Q49270687-354BC3C9-ADD7-4C2A-B6EC-61FA9AC6D74BQ50737014-81807021-8565-4463-A333-E669A757B529Q52584422-5183355D-47F3-4C9A-91EB-627010C11113Q52715734-268E17ED-102B-4F00-A115-9767434D6EC4
P2860
Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucosal adjuvants and long-ter ...... other ADP-ribosylating toxins.
@en
Mucosal adjuvants and long-ter ...... other ADP-ribosylating toxins.
@nl
type
label
Mucosal adjuvants and long-ter ...... other ADP-ribosylating toxins.
@en
Mucosal adjuvants and long-ter ...... other ADP-ribosylating toxins.
@nl
prefLabel
Mucosal adjuvants and long-ter ...... other ADP-ribosylating toxins.
@en
Mucosal adjuvants and long-ter ...... other ADP-ribosylating toxins.
@nl
P2860
P356
P1433
P1476
Mucosal adjuvants and long-ter ...... other ADP-ribosylating toxins.
@en
P2860
P2888
P304
P356
10.1038/MI.2010.54
P577
2010-09-15T00:00:00Z